Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 487-491 , September 2010

Is residual neurovascular tissue on prostatectomy specimens associated with surgeon intent at nerve-sparing and postoperative quality of life measures?

  • Timothy J. Bradford, M.D.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA
  • ,
  • Alon Z. Weizer, M.D.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-734-936-8063; fax: +1-734-936-9127
  • ,
  • Scott M. Gilbert, M.D.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA
  • ,
  • Rodney L. Dunn, M.S.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA
    • Department of Biostatistics, Ann Arbor, MI 48109, USA
  • ,
  • Kirk Wojno, M.D.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA
    • Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
  • ,
  • Rajal Shah, M.D.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA
    • Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA
  • ,
  • David P. Wood, M.D.

      Affiliations

    • Department of Urology, Ann Arbor, MI 48109, USA

Received 22 July 2008 ,Revised 30 September 2008 ,Accepted 30 September 2008.

References 

  1. Kundu SD, Roehl KA, Eggener SE, et al. Potency, continence, and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol. 2004;172:2227–2231
  2. Quinlan DM, Epstein JI, Carter BS, et al. Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. J Urol. 1991;145:998–1002
  3. Rabbani F, Stapleton AM, Kattan MW, et al. Factors predicting recovery of erections after radical prostatectomy. J Urol. 2000;164:1929–1934
  4. Walsh PC, Donker PJ. Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol. 1982;128:492–497
  5. Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations. Prostate. 1983;4:473–485
  6. Walsh PC, Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency (Results using a new nerve-sparing technique). Br J Urol. 1984;56:694–697
  7. Twiss C, Slova D, Lepor H. Outcomes for men younger than 50 years undergoing radical prostatectomy. Urology. 2005;66:141–146
  8. Hollenbeck BK, Dunn RL, Wei JT, et al. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol. 2003;169:1453–1457
  9. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135
  10. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905
  11. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20:557–566
  12. Benoit RM, Naslund MJ, Cohen JK. Complications after radical retropubic prostatectomy in the Medicare population. Urology. 2000;56:116–120
  13. Hu JC, Gold KF, Pashos CL, et al. Temporal trends in radical prostatectomy complications from 1991 to 1998. J Urol. 2003;169:1443–1448
  14. Penson DF, McLerran D, Feng Z, et al. Five-year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. J Urol. 2005;173:1701–1705
  15. Walsh PC, Marschke P, Ricker D, et al. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000;55:58–61
  16. Haffner MC, Landis PK, Saigal CS, et al. Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: Impact of neurovascular bundle preservation. Urology. 2005;66:371–376

PII: S1078-1439(08)00265-2

doi: 10.1016/j.urolonc.2008.09.042

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 487-491 , September 2010